Aurobindo Pharma

Aurobindo Pharma subsidiary signs strategic collaboration for respiratory products with global pharma

Lupin and Aurobindo Pharma shares in focus on positive US generics outlook; Macquarie sees potential rally

Aurobindo Pharma shares jump 2% after BOCAPS upgrades to ‘Buy’ rating

Aurobindo Pharma gets USFDA nod for Cephalexin Tablets USP, 250 mg and 500 mg

Aurobindo Pharma shares fall 3% after US FDA issues 10 observations after inspection

Aurobindo Pharma faces setback as US FDA issues 10 observations after inspection

UBS initiates Sell call on Zydus, Dr Reddy’s, Aurobindo Pharma, Lupin

UBS has initiated sell ratings on key Indian pharmaceutical stocks including Zydus, Dr. Reddy's, Aurobindo, and Lupin, citing overestimated core margins and slow growth in their primary markets of India and the US.

Eugia Steriles receives US FDA clearance for injectable facility

LIC reduces stake in Aurobindo Pharma to 2.26% from 5.01%

Aurobindo Pharma share jumps 4% after Eugia Steriles gets USFDA nod for anesthetic drug

Aurobindo Pharma’s Eugia Steriles gets USFDA nod for Lidocaine Hydrochloride injection

Aurobindo Pharma shares fall 5% after USFDA warning letter for Eugia Unit-III

Aurobindo Pharma shares jump after US FDA approval on Estradiol Vaginal Inserts USP

Aurobindo Pharma board approves buyback of 51 lakh shares worth Rs 750 crore at Rs 1,460

The board of Aurobindo Pharma has today approved a buyback of its shares via the tender route. The company said that it will buyback 51.4 lakh shares at Rs 1,460 per share. The total buyback size will be around Rs 750 crore

Kejriwal’s allegations against BJP gives rise to controversy

Kejriwal claimed that Sarath Reddy, son of Aurobindo Pharma founder PV Ram Prasad Reddy, was made to pay a massive sum of ₹55 crore as protection money to the BJP.